Gene · 54567
Papers4,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficient generation of human NOTCH ligand-expressing haemogenic endothelial cells as infrastructure for in vitro haematopoiesis and lymphopoiesis. | Nat Commun | 2024 | 39227582 | PubTator, text mining | PubMed |
| Circ_0006476 modulates macrophage apoptosis through the miR-3074-5p/DLL4 axis: implications for Notch signalling pathway regulation in cardiovascular disease. | Aging (Albany NY) | 2024 | 39167432 | PubTator, text mining | PubMed |
| Engineering synthetic agonists for targeted activation of Notch signaling. | bioRxiv | 2024 | 39149362 | PubTator, text mining | PubMed |
| Mitochondria Transplantation to Bone Marrow Stromal Cells Promotes Angiogenesis During Bone Repair. | Adv Sci (Weinh) | 2024 | 39137351 | PubTator, text mining | PubMed |
| Modulating endothelial cell dynamics in fat grafting: the impact of DLL4 siRNA via adipose stem cell extracellular vesicles. | Am J Physiol Cell Physiol | 2024 | 39099421 | PubTator, text mining | PubMed |
| Arachidonic acid metabolism regulates the development of retinopathy of prematurity among preterm infants. | J Neurochem | 2024 | 39073120 | PubTator, text mining | PubMed |
| Agrimonolide mitigated DSS-induced colitis by modulating the balance between Treg and Th17 cells through the suppression of the Notch and JAK2/STAT3 signaling pathways. | Heliyon | 2024 | 39071599 | PubTator, text mining | PubMed |
| The Prediction of DLL4 as a Prognostic Biomarker in Patients with Gastric Cancer Using Anti-DLL4 Nanobody. | J Gastrointest Cancer | 2024 | 39046662 | PubTator, text mining | PubMed |
| Generation and repair of thymic epithelial cells. | J Exp Med | 2024 | 38980292 | PubTator, text mining | PubMed |
| Another Notch in the Belt of Rheumatoid Arthritis. | Arthritis Rheumatol | 2024 | 38961731 | PubTator, text mining | PubMed |
| Characterization of expression patterns and dynamic relocation of Notch proteins during acrosome reaction of bull spermatozoa. | Sci Rep | 2024 | 38942812 | PubTator, text mining | PubMed |
| Molecular hydrogen promotes retinal vascular regeneration and attenuates neovascularization and neuroglial dysfunction in oxygen-induced retinopathy mice. | Biol Res | 2024 | 38915069 | PubTator, text mining | PubMed |
| COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC. | Future Oncol | 2024 | 38861293 | PubTator, text mining | PubMed |
| BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension. | Int J Mol Sci | 2024 | 38791441 | PubTator, text mining | PubMed |
| Exosomes: A New Hope for Angiogenesis-Mediated Bone Regeneration. | Int J Mol Sci | 2024 | 38791243 | PubTator, text mining | PubMed |
| Endothelial to mesenchymal Notch signaling regulates skeletal repair. | JCI Insight | 2024 | 38781018 | PubTator, text mining | PubMed |
| Endothelial HIF2α suppresses retinal angiogenesis in neonatal mice by upregulating NOTCH signaling. | Development | 2024 | 38770916 | PubTator, text mining | PubMed |
| Mechanoresponsive ETS1 causes endothelial dysfunction and arterialization in varicose veins via NOTCH4/DLL4 signaling. | Eur J Cell Biol | 2024 | 38759515 | PubTator, text mining | PubMed |
| Environmentally relevant concentrations of benzophenones exposure disrupt intestinal homeostasis, impair the intestinal barrier, and induce inflammation in mice. | Environ Pollut | 2024 | 38614423 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Lung Adenocarcinoma and Brain Metastasis through Integrated Single-Cell Transcriptomics. | Int J Mol Sci | 2024 | 38612588 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54567/papers?page=10